Angela Gentile1, María Del Valle Juarez2, María Florencia Lucion3, Ana Clara Martínez4, Viviana Romanin5, Soledad Areso6, Alicia Mistchenko7. 1. "R. Gutiérrez" Children's Hospital, Epidemiology, 1330 Gallo St, PO 1425, Buenos Aires, Argentina. Electronic address: angelagentile21@gmail.com. 2. "R. Gutiérrez" Children's Hospital, Epidemiology, 1330 Gallo St, PO 1425, Buenos Aires, Argentina. Electronic address: epidemiologiaguti@gmail.com. 3. "R. Gutiérrez" Children's Hospital, Epidemiology, 1330 Gallo St, PO 1425, Buenos Aires, Argentina. Electronic address: flor_lucion@yahoo.com. 4. "R. Gutiérrez" Children's Hospital, Epidemiology, 1330 Gallo St, PO 1425, Buenos Aires, Argentina. Electronic address: anaclaramartinez@gmail.com. 5. "R. Gutiérrez" Children's Hospital, Epidemiology, 1330 Gallo St, PO 1425, Buenos Aires, Argentina. Electronic address: vivianaromanin@gmail.com. 6. "R. Gutiérrez" Children's Hospital, Epidemiology, 1330 Gallo St, PO 1425, Buenos Aires, Argentina. Electronic address: aresosoledad@gmail.com. 7. "R. Gutiérrez" Children's Hospital, Virology, 1330 Gallo St, PO 1425, Buenos Aires, Argentina. Electronic address: asmistchenko@hotmail.com.
Abstract
INTRODUCTION: Whooping cough continues to be a major cause of morbidity and mortality in infants younger than 1 year. In 2012, Argentina introduced Tdap in pregnancy to prevent infant mortality. The aim of this study is to describe the impact of maternal immunization on the hospitalization and mortality rates of confirmed Bordetella pertussis (Bp) cases by comparing pre- and post-Tdap vaccine recommendation periods. MATERIAL AND METHODS: All PCR-confirmed Bp cases from "R. Gutierrez" Children's Hospital identified between December 2003 and December 2016 were included in. Analysis was performed comparing hospitalization rates (per 10,000 discharges) between pre-vaccination (PreV) 2003-2011 and post-vaccination (PostV) 2013-2016 time periods, excluding the intervention year (2012). RESULTS: During the study time frame, there were 1046 suspected Bp cases, of which 337 (32.2%) were confirmed. Three-hundred eight cases were analyzed (excluding year 2012): 237 in PreV and 71 in PostV. In comparison with PreV, PostV cases were older (3 vs 9 months; p < 0.001), and required less hospitalization (86.9% vs 67.6%; p < 0.001). Bp hospitalization rate (HR) decreased (22.3 vs 11.6; p < 0.001). The mortality rate in PreV 5.9% (14 cases); there were not deaths during PostV (p = 0.036). CONCLUSIONS: Confirmed cases were among infants younger than 1 year In PostV, Bp cases were older and there was a significant decrease in the hospitalization rate. There were no fatal cases in our center after the pregnancy Tdap recommendation was implemented.
INTRODUCTION: Whooping cough continues to be a major cause of morbidity and mortality in infants younger than 1 year. In 2012, Argentina introduced Tdap in pregnancy to prevent infant mortality. The aim of this study is to describe the impact of maternal immunization on the hospitalization and mortality rates of confirmed Bordetella pertussis (Bp) cases by comparing pre- and post-Tdap vaccine recommendation periods. MATERIAL AND METHODS: All PCR-confirmed Bp cases from "R. Gutierrez" Children's Hospital identified between December 2003 and December 2016 were included in. Analysis was performed comparing hospitalization rates (per 10,000 discharges) between pre-vaccination (PreV) 2003-2011 and post-vaccination (PostV) 2013-2016 time periods, excluding the intervention year (2012). RESULTS: During the study time frame, there were 1046 suspected Bp cases, of which 337 (32.2%) were confirmed. Three-hundred eight cases were analyzed (excluding year 2012): 237 in PreV and 71 in PostV. In comparison with PreV, PostV cases were older (3 vs 9 months; p < 0.001), and required less hospitalization (86.9% vs 67.6%; p < 0.001). Bp hospitalization rate (HR) decreased (22.3 vs 11.6; p < 0.001). The mortality rate in PreV 5.9% (14 cases); there were not deaths during PostV (p = 0.036). CONCLUSIONS: Confirmed cases were among infants younger than 1 year In PostV, Bp cases were older and there was a significant decrease in the hospitalization rate. There were no fatal cases in our center after the pregnancy Tdap recommendation was implemented.
Authors: María Del Rosario León-Morillo; David Gomez-Pastrana; María Cruz Díaz-Colom; Sonia Quecuty-Vela; Juan Carlos Alados-Arboledas; Carmen Aragón-Fernández Journal: Enferm Infecc Microbiol Clin (Engl Ed) Date: 2022-06-09
Authors: Viviana Romanin; Anna M Acosta; Maria Del Valle Juarez; Elizabeth Briere; Stella Maris Sanchez; Beatriz Lopez Cordoba; Maria Eugenia Sevilla; Maria Florencia Lucion; Anahi Urrutia; Sandra Sagradini; Tami H Skoff; Carla Vizzotti Journal: Clin Infect Dis Date: 2020-01-16 Impact factor: 9.079
Authors: Petra Zimmermann; Kirsten P Perrett; Nicole L Messina; Susan Donath; Nicole Ritz; Fiona R M van der Klis; Nigel Curtis Journal: EClinicalMedicine Date: 2019-07-26
Authors: Pablo Martin Aispuro; Nicolás Ambrosis; María Eugenia Zurita; María Emilia Gaillard; Daniela Bottero; Daniela Flavia Hozbor Journal: Front Microbiol Date: 2020-04-17 Impact factor: 5.640
Authors: Frederico Friedrich; Maria Clara Valadão; Marcos Brum; Talitha Comaru; Paulo Márcio Pitrez; Marcus Herbert Jones; Leonardo A Pinto; Marcelo C Scotta Journal: PLoS One Date: 2020-01-28 Impact factor: 3.240
Authors: Nicoline A T van der Maas; Elisabeth A M Sanders; Florens G A Versteegh; Albertine Baauw; Anneke Westerhof; Hester E de Melker Journal: BMC Infect Dis Date: 2019-10-29 Impact factor: 3.090